Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right ...

Body mass index (BMI) has long been a common tool for estimating a person's relative weight status based on a simple height to weight ratio. It's easy to calculate, widely accessible and often used ...

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

You can use the CDC’s BMI calculator to get your number ... like liraglutide (Saxenda) and tirzepatide (Zepbound and Mounjaro), support weight loss by reducing appetite. Finally, supplements for ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Over the past month, studies have shown Zepbound leads to more weight loss than Wegovy, and GLP-1 drugs may lower obesity-related cancer risk better than bariatric surgery. Here are eight quick ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

How Ozempic’s Maker Lost Its Grip on the Obesity Market It Created ...

Eli Lilly's growth is impressive, but its current valuation is only justifiable with sustained high growth. Click here to ...

"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.